Prospective Study on the Use of Transdermal Analgesic Buprenorphine Patches for Chronic Pain in the UK.
Phase of Trial: Phase IV
Latest Information Update: 11 Apr 2014
At a glance
- Drugs Buprenorphine (Primary)
- Indications Pain
- Focus Adverse reactions
- Sponsors Mundipharma International
- 13 Feb 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 12 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 25 Oct 2012 Planned end date changed from 1 Sep 2011 to 1 Nov 2013 as reported by ClinicalTrials.gov.